Can a new protein drug shield kids with cancer from dangerous infections?
NCT ID NCT07724756
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This trial tests whether a new drug called albipagrastim alfa can prevent severe neutropenia (dangerously low white blood cell counts) in children with sarcoma who are receiving chemotherapy. The drug is designed to stimulate the body's production of infection-fighting neutrophils. Researchers will measure how the drug behaves in the body, how well it protects against fever and infection, and whether it is safe for young patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a new drug called albipagrastim alfa (QLC2519) that stimulates white blood cell production
- What this could lead to
- If it works, this could offer a safer, more convenient way to prevent dangerous infections in children undergoing chemotherapy for sarcoma.
- What could go wrong
- This is a small, early-phase trial with only 18 participants, so results may not apply broadly. The drug could cause side effects or fail to prevent neutropenia as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEBRILE NEUTROPENIA (FN) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Children's Hospital
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can two drugs together fight Hard-to-Treat bone and Soft-Tissue cancers?
- Can a safer dose of an old drug shield vulnerable children from deadly fungal infections?
- Can a new drug ST316 shrink Hard-to-Treat tumors?
- New PET tracer could sharpen sarcoma detection
- Hip muscle repair method may improve walking after bone cancer surgery
- Could an ALS drug clear the fog of chemo brain?